Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sascha Barabas
Observed names:
Barabas, Sascha,
S Barabas,
S. Barabas
Institution:
Lophius Biosciences (Germany)
Observed institutions:
TUM Klinikum,
University Hospital Regensburg,
Institute of Medical Microbiology and Hygiene,
Lophius Biosciences (Germany),
University of Regensburg,
Technical University of Munich
show all 6
OpenAlex ID:
A5024085555
An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity
2017
·
Sascha Barabas
, Theresa Spindler
, et al.
·
BMC Immunology
·
68
PDF
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation
2019
·
Eva Wagner-Drouet
, Daniel Teschner
, et al.
·
Haematologica
·
54
PDF
Characterization of theHelicobacter pyloriCysteine-Rich Protein A as a T-Helper Cell Type 1 Polarizing Agent
2005
·
Ludwig Deml
, Michael Aigner
, et al.
·
Infection and Immunity
·
45
Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients
2017
·
Bernhard Banas
, Carsten A. Böger
, et al.
·
BMC Immunology
·
43
PDF
CD4+T Helper Cell Responses against Human Bocavirus Viral Protein 2 Viruslike Particles in Healthy Adults
2008
·
Juha Lindner
, Sandra Zehentmeier
, et al.
·
The Journal of Infectious Diseases
·
39
PDF
Clinical validation of a novel enzyme-linked immunosorbent spot assay-basedin vitrodiagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
2017
·
Bernhard Banas
, Dominik Steubl
, et al.
·
Transplant International
·
38
PDF
Urea-Mediated Cross-Presentation of Soluble Epstein-Barr Virus BZLF1 Protein
2008
·
Sascha Barabas
, Regina Gary
, et al.
·
PLoS Pathogens
·
25
PDF
CD4+ T‐Cell Responses Against the VP1‐Unique Region in Individuals with Recent and Persistent Parvovirus B19 Infection
2005
·
J. Lindner
, S. Barabas
, et al.
·
Journal of Veterinary Medicine Series B
·
21
Functional impairment of CMV‐reactive cellular immunity during pregnancy
2016
·
Edith Reuschel
, Sascha Barabas
, et al.
·
Journal of Medical Virology
·
17
Stimulatory Effect of CMV Immunoglobulin on Innate Immunity and on the Immunogenicity of CMV Antigens
2021
·
Ludwig Deml
, Christian M. Hüber
, et al.
·
Transplantation Direct
·
10
Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation
2021
·
Eva Wagner-Drouet
, Daniel Teschner
, et al.
·
Diagnostics
·
5
PDF
Performance of T-Track® SARS-CoV-2, an Innovative Dual Marker RT-qPCR-Based Whole-Blood Assay for the Detection of SARS-CoV-2-Reactive T Cells
2023
·
Franziska M. Kanis
, Johannes P. Meier
, et al.
·
Diagnostics
·
3
PDF
Performance of T-Track® TB, a Novel Dual Marker RT-qPCR-Based Whole-Blood Test for Improved Detection of Active Tuberculosis
2023
·
Johannes P. Meier
, Selina Möbus
, et al.
·
Diagnostics
·
3
PDF
Clinical Validation of T-track (r) Cmv to Assess the Functionality of Cmv-specific Cell-mediated Immunity in Kidney Transplant Recipients
2016
·
Bernhard Banas
, Dominik Steubl
, et al.
·
RWTH Publications (RWTH Aachen)
·
1
Comparison of the composition of fetal and maternal immune effector cells upon prenatal microbial infections during the second and third trimester of pregnancy
2021
·
E Reuschel
, S Barabas
, et al.
·
Zeitschrift für Geburtshilfe und Neonatologie
Clinical Validation of a Novel Elispot-Based Diagnostic Assay: Monitoring Cytomegalovirus-Specific Cell-Mediated Immunity and Risk Stratification in Hematopoietic Stem Cell Transplant Recipients
2019
·
Eva Wagner
, Daniel Teschner
, et al.
·
Transplantation and Cellular Therapy
PDF
1575. Clinical Validation of a Novel ELISpot-based in vitro Diagnostic Assay to Monitor CMV-Specific Cell-Mediated Immunity in SOT and HSCT Immunocompromised Patients
2018
·
Bernhard Banas
, Dominik Steubl
, et al.
·
Open Forum Infectious Diseases
Clinical Validation of a Novel ELISpot-based in Vitro Diagnostic Assay to Monitor CMV-specific Cell-Mediated Immunity in Kidney Transplant Recipients
2018
·
Bernhard Banas
, Dominik Steubl
, et al.
·
Transplantation
Mp315clinical Validation of a Novel Elispot-based in Vitro Diagnostic Assay to Monitor Cmv-specific Cell-mediated Immunity in Kidney Transplant Recipients
2017
·
Bernhard Banas
, Dominik Steubl
, et al.
·
Nephrology Dialysis Transplantation
Additional file 1: of Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients
2017
·
Banas, Bernhard
, Böger, Carsten
, et al.
·
Figshare
Additional File 3:
2017
·
Barabas, Sascha
, Spindler, Theresa
, et al.
·
Figshare
Additional File 2:
2017
·
Barabas, Sascha
, Spindler, Theresa
, et al.
·
Figshare
Additional File 1:
2017
·
Barabas, Sascha
, Spindler, Theresa
, et al.
·
Figshare
Evaluation of T-Track® CMV to assess the functionality of Cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients
2016
·
Katharina Boeckl
, Bernhard Banas
, et al.
·
The Journal of Immunology
An optimized IFN-γ ELISpot assay using T-activated ® ;proteins for determination of CMV-specific cell-mediated immunity
2016
·
Katharina Boeckl
, Nina Körber
, et al.
·
The Journal of Immunology
Show more works
View as search
Works count:
39
Citation count:
372
H-index:
10
I10-index:
10
Year
Topic
Type